Phase III Clinical Trial of Sabin Strain Inactivated Poliovirus Vaccine (Vero Cell)

Summary

The study aimed to evaluate the safety and immunogenicity of a Sabin strain-based inactivated polio vaccine in infants aged two months (60\~89 days).

Timeline

Start

2017-08-21

Primary completion

2023-04-10

Completion

2023-04-10

Drugs

Indications